Free press releases distribution network?

Agency / Source: Werbeagentur & PR-Agentur co-operate

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Diapharm Organizes API/GMP Audits - Increased Safety through Accredited, Cost-efficient Audits Published for in Europe, China and India - In 2010, the pharma service provider Diapharm is going to conduct third-party API audits in Europe, China and India. Medicinal product manufacturers in Europe must audit their API suppliers regularly, either by themselves or through a third-party
Diapharm Organizes API/GMP Audits - Increased Safety through Accredited, Cost-efficient Audits Published for in Europe, China and India

 

PRZOOM - /newswire/ - Muenster, North Rhine-Westfalia, Germany, 2010/03/08 - In 2010, the pharma service provider Diapharm is going to conduct third-party API audits in Europe, China and India. Medicinal product manufacturers in Europe must audit their API suppliers regularly, either by themselves or through a third-party.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

In 2010, the pharmaceutical service provider Diapharm is again offering worldwide API/GMP audits of API manufacturing sites with a focus on Europe, China and India. Diapharm made this announcement on the occasion of the DIA Annual Euro Meeting in Monaco. During these trips, different active pharmaceutical ingredients (APIs) from different customers are audited for GMP compliance, grouped together by API manufacturing site and region. This audit sharing is extremely cost-efficient. “With these accredited third-party audits, we enable pharmaceutical companies to control their API production at the highest level,” explains Martin Vortkamp, who is in charge of the shared audit service at Diapharm. “The confidentiality interests of all participating companies have always highest priority.”

Pharmaceutical companies in Europe are obliged to guarantee the quality of their APIs used for the production of medicinal products. In order to do this, they must periodically audit their suppliers according to Good Manufacturing Practice (GMP). The growing number of CEP suspensions and revocations shows the urgency of these inspections. “Since we established this business with accredited audits in 2008, Diapharm (diapharm.com) has already audited over 50 APIs – from Alfuzosin from the Czech Republic to Venlafaxine from India,” says Martin Vortkamp. Usually the audits are performed by our partner the blue inspection body GmbH, an independent (Type A inspection body) Third-Party-Audit provider accredited according to ISO/IEC 17020 for the 'inspection of excipients and active pharmaceutical ingredient manufacturers for pharmaceutical products'. The audit reports are normally available for sale to other interested companies as well.

Additional information about planned audit trips in 2010 is available from Karin Müller, Diapharm GmbH
T: +49 (0)251 60935-511
E: karin.mueller[.]diapharm.com.

The full list of audit reports is available online.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Werbeagentur & PR-Agentur co-operate

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Diapharm Organizes API/GMP Audits - Increased Safety through Accredited, Cost-efficient Audits Published for in Europe, China and India

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Christian Rieke - Co-Operate.net 
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Werbeagentur & PR-Agentur co-operate securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Werbeagentur & PR-Agentur co-operate / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

First Pulmonary Embolism Patients in Hong Kong Treated with the EKOS® System
Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Genentech’s Cancer Immunotherapy Tecentriq® (Atezolizumab) Priority Review in Additional Type of Advanced Bladder Cancer
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) for Myopic Choroidal Neovascularization
Sugar Element of Keratan Sulfate Halts the Progress of Emphysema Finds RIKEN
Exelixis and Ipsen Amend Exclusive Licensing Agreement for the Commercialization and Development of Cabozantinib to Include Canada
FDA Extends Review of Application for OCREVUS™ (Ocrelizumab)
MDxHealth Announces AceCGT Life Science Limited as the Exclusive Distributor for SelectMDx in Hong Kong and Macao China
Pulse Certified As A Level Four Multichannel Content Agency by Veeva Systems
BD Launches Advanced Prefillable Syringe for Higher Volume Injection of Biologics

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  JobsWare.com

Visit  Intrinsic Executive Search Ltd

Visit  La Bella Bakery Artisan Bakery Arizona







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today